Similar articles for PMID: 29315390

Year	Number of Results
1968	1
1986	2
1995	1
1997	4
1998	1
1999	3
2000	1
2001	1
2003	1
2004	4
2006	2
2007	3
2008	4
2009	10
2010	8
2011	7
2012	6
2013	5
2014	5
2015	10
2016	5
2017	3
2018	6
2019	2
2020	1
2021	2
2022	1
2024	0

1

Probable vancomycin-induced myasthenic crisis: a case report.

Nguyen CT, Nanfro J. Nguyen CT, et al. J Antimicrob Chemother. 2018 Apr 1;73(4):1106-1108. doi: 10.1093/jac/dkx514. J Antimicrob Chemother. 2018. PMID: 29315390 No abstract available.

2

Is high minimal inhibitory concentration of vancomycin a predictor of poor response in MRSA infections?

Faulhaber G, Zavascki A, Fuchs SC. Faulhaber G, et al. Arch Intern Med. 2007 Jun 11;167(11):1206-7; author reply 1208-9. doi: 10.1001/archinte.167.11.1206-b. Arch Intern Med. 2007. PMID: 17563032 No abstract available.

3

Vancomycin levels, efficacy, and toxicity.

Johnson JR. Johnson JR. Arch Intern Med. 2007 Jun 11;167(11):1207; author reply 1208-9. doi: 10.1001/archinte.167.11.1207-a. Arch Intern Med. 2007. PMID: 17563035 No abstract available.

4

Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels.

Walsh SN, Kerchner K, Sangüeza OP. Walsh SN, et al. Arch Dermatol. 2009 May;145(5):603-4. doi: 10.1001/archdermatol.2009.68. Arch Dermatol. 2009. PMID: 19451516 No abstract available.

5

[New guidelines for vancomycin in staphylococcal infections].

Giske CG, Odenholt I, Kahlmeter G. Giske CG, et al. Lakartidningen. 2010 Mar 17-23;107(11):742. Lakartidningen. 2010. PMID: 20402263 Swedish. No abstract available.

6

A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.

Kalimuddin S, Chan YFZ, Phillips R, Ong SP, Archuleta S, Lye DC, Tan TT, Low JGH. Kalimuddin S, et al. Trials. 2018 Jun 1;19(1):305. doi: 10.1186/s13063-018-2702-8. Trials. 2018. PMID: 29859132 Free PMC article. Clinical Trial.

7

Daptomycin or vancomycin for methicillin-resistant Staphylococcus aureus with a vancomycin minimum inhibitory concentration >1 μg/L.

López-Cortés LE, Pascual Á, Rodríguez-Baño J. López-Cortés LE, et al. Clin Infect Dis. 2012 May;54(9):1375-6; author reply 1376-7. doi: 10.1093/cid/cis123. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460977 No abstract available.

8

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Moore CL, et al. Clin Infect Dis. 2012 Jan 1;54(1):51-8. doi: 10.1093/cid/cir764. Epub 2011 Nov 21. Clin Infect Dis. 2012. PMID: 22109947

9

Vancomycin-induced thrombocytopenia.

Govindarajan R, Baxter D, Wilson C, Zent C. Govindarajan R, et al. Am J Hematol. 1999 Oct;62(2):122-3. doi: 10.1002/(sici)1096-8652(199910)62:2<122::aid-ajh14>3.0.co;2-r. Am J Hematol. 1999. PMID: 10509053 Free article. No abstract available.

10

Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management.

Changela A, Javaiya H, Rickenback K, Elnawawi A, Changela K. Changela A, et al. Am J Ther. 2013 Mar-Apr;20(2):223-5. doi: 10.1097/MJT.0b013e3181f94c27. Am J Ther. 2013. PMID: 21273948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year